Healthcare


Ipsos Update Publication

Ipsos Update – January 2026

2025, 2026, Predictions … Ipsos Update explores the latest research and thinking on key topics from Ipsos teams around the world.

Almost a quarter of the world’s women are not comfortable talking about menopause

Menopause is something that all women on the planet will potentially experience in their lives and yet is still something of a taboo to many. New research by Ipsos across 33 countries looks at attitudes towards menopause around the world.
Healthcare Survey

Nutrition in a pill: Europeans’ attitudes towards food supplements

Ipsos European Public Affairs' findings show that food supplements and vitamins have become an essential part of European consumers’ lifestyle
Healthcare Survey

3 in 5 globally say their healthcare system is overstretched

However, half of those surveyed across 34 countries describe the quality of their country’s healthcare service as good.

Ipsos Update Publication

Ipsos Update - October 2022

Sustainability, inflation, healthcare… Ipsos Update explores the latest and greatest research & thinking on key topics from Ipsos around the world.

What Worries the World - February 2022

The global public’s top 5 concerning issues remain unchanged, with Covid-19 still top. But inflation now ranks 6th with almost one in four (23%) worldwide now saying it is a worry in their country.
Public Health Survey

Global Health Service Monitor 2021

Public perceptions of healthcare services have not been adversely affected by the pandemic, according to our 30-country survey. People continue to see coronavirus as the main health problem facing their country, while concern about mental health increases.
Healthcare Publication

透過IBN (貝氏網路) 精準分析醫藥業代服務績效

醫藥業代代表製藥公司,透過即時、準確、可靠且科學化的服務,全力支持各個專長領域的醫生,以獲得最高的滿意度。Sales representative is representing pharmaceutical company to provide physicians across therapy areas with services to support them in attaining the goals with the highest satisfaction, by providing timely, accurate and reliable scientific engagement and services.
Healthcare Publication

氣喘與慢性阻塞性肺病的趨勢及變化

肺阻塞佔世界死因排名第四,預估將持續攀升。越來越多國際藥廠投入相關治療用藥,市場也發生了明顯的變化。LABA聯合LAMA將取代ICS聯合LABA FDC,成為肺阻塞的主要治療選擇並持續增長。而ICS聯合LABA FDC在氣喘治療的競爭更加激烈,差異化需求逐漸增加。
Chronic obstructive pulmonary disease (COPD) is now the fourth leading cause of death worldwide and is predicted by WHO to become the third by 2030. More and more international pharmaceuticals have increased investment in treatments for respiratory diseases, bringing significant changes to COPD and Asthma treatment market. LABA/LAMA has replaced ICS/LABA FDC to become the leading treatment choice for COPD and will continue its growth. We also found Increased competition of ICS/LABA FDC as asthma treatment, as well as the needs for differentiation.